Timing of vasopressin initiation influences renal outcomes in mixed cardiogenic-vasodilatory shock supported by VA-ECMO
Early vasopressin administration in VA-ECMO-supported mixed shock may reduce the incidence of acute kidney injury compared with no vasopressin use, without increasing adverse events. Prospective studies are warranted to confirm these findings and to determine the optimal timing of vasopressin therapy in this high-risk population.
Authors
- Maxime Nguyen (ORCID: https://orcid.org/0000-0002-2334-1487)
- Vivien Berthoud (ORCID: https://orcid.org/0000-0001-9086-8695)
- Bélaïd Bouhemad (ORCID: https://orcid.org/0000-0002-6124-2156)
- Christophe Beyls (ORCID: https://orcid.org/0000-0001-8949-7348)
- Guinot Pierre-Grégoire
- Osama Abou-Ara
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Maison des Sciences sociales et des Humanités de Dijon (FR)
Publication Details
- Journal
- Anaesthesia Critical Care & Pain Medicine
- Published
- 2025-11-08
- DOI
- https://doi.org/10.1016/j.accpm.2025.101670
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00